125 related articles for article (PubMed ID: 24584550)
21. Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study.
McGrath RT; Hocking SL; Priglinger M; Day S; Herkes GK; Krause M; Fulcher GR
BMJ Open; 2016 Feb; 6(2):e008203. PubMed ID: 26911582
[TBL] [Abstract][Full Text] [Related]
22. [The impact of acute hyperglycemia on the prognosis of ST-segment elevation myocardial infarction].
; Zhao W; Hu DY
Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):820-3. PubMed ID: 18218232
[TBL] [Abstract][Full Text] [Related]
23. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction.
Ibanez B; Fuster V; Macaya C; Sánchez-Brunete V; Pizarro G; López-Romero P; Mateos A; Jiménez-Borreguero J; Fernández-Ortiz A; Sanz G; Fernández-Friera L; Corral E; Barreiro MV; Ruiz-Mateos B; Goicolea J; Hernández-Antolín R; Acebal C; García-Rubira JC; Albarrán A; Zamorano JL; Casado I; Valenciano J; Fernández-Vázquez F; de la Torre JM; Pérez de Prado A; Iglesias-Vázquez JA; Martínez-Tenorio P; Iñiguez A
Am Heart J; 2012 Oct; 164(4):473-480.e5. PubMed ID: 23067904
[TBL] [Abstract][Full Text] [Related]
24. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
[TBL] [Abstract][Full Text] [Related]
25. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
[TBL] [Abstract][Full Text] [Related]
26. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
[TBL] [Abstract][Full Text] [Related]
27. Ruptured plaque is associated with larger infarct size following successful percutaneous coronary intervention in ST segment elevation acute myocardial infarction.
Tanaka A; Shimada K; Namba M; Sano T; Sakamoto T; Akasaka T; Yoshikawa J
Coron Artery Dis; 2009 Jun; 20(4):260-6. PubMed ID: 19424058
[TBL] [Abstract][Full Text] [Related]
28. [Impact of mean fasting glucose over the first 72 hours on in-hospital outcomes of patients with ST-segment elevation myocardial infarction].
Liu PM; Lin FN; Fang C; Zhang SL; Wang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1073-6. PubMed ID: 21215139
[TBL] [Abstract][Full Text] [Related]
29. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
[TBL] [Abstract][Full Text] [Related]
30. Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial.
Scholte M; Timmers L; Bernink FJ; Denham RN; Beek AM; Kamp O; Diamant M; Horrevoets AJ; Niessen HW; Chen WJ; van Rossum AC; van Royen N; Doevendans PA; Appelman Y
Trials; 2011 Nov; 12():240. PubMed ID: 22067476
[TBL] [Abstract][Full Text] [Related]
31. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK.
Su H; Sun X; Ma H; Zhang HF; Yu QJ; Huang C; Wang XM; Luan RH; Jia GL; Wang HC; Gao F
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E629-35. PubMed ID: 17519283
[TBL] [Abstract][Full Text] [Related]
32. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h.
Busk M; Kaltoft A; Nielsen SS; Bøttcher M; Rehling M; Thuesen L; Bøtker HE; Lassen JF; Christiansen EH; Krusell LR; Andersen HR; Nielsen TT; Kristensen SD
Eur Heart J; 2009 Jun; 30(11):1322-30. PubMed ID: 19357105
[TBL] [Abstract][Full Text] [Related]
33. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
34. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.
Desmet W; Bogaert J; Dubois C; Sinnaeve P; Adriaenssens T; Pappas C; Ganame J; Dymarkowski S; Janssens S; Belmans A; Van de Werf F
Eur Heart J; 2011 Apr; 32(7):867-77. PubMed ID: 21196444
[TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
36. [Admission hyperglycemia and mortality of ST segment elevation myocardial infarction].
Greig D; Corbalán R; Castro P; Campos P; Lamich R; Yovaniniz P; Nazzal C
Rev Med Chil; 2010 Sep; 138(9):1109-16. PubMed ID: 21249278
[TBL] [Abstract][Full Text] [Related]
37. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).
Palmerini T; Brener SJ; Genereux P; Maehara A; Della Riva D; Mariani A; Witzenbichler B; Godlewski J; Parise H; Dambrink JH; Ochala A; Fahy M; Xu K; Gibson CM; Stone GW
Am J Cardiol; 2013 Dec; 112(12):1860-6. PubMed ID: 24063843
[TBL] [Abstract][Full Text] [Related]
38. Relation of ST-segment elevation before and after percutaneous transluminal coronary angioplasty to left ventricular area at risk, myocardial infarct size, and systolic function.
Rodríguez-Palomares JF; Figueras-Bellot J; Descalzo M; Moral S; Otaegui I; Pineda V; Del Blanco BG; González-Alujas MT; Evangelista Masip A; García-Dorado D
Am J Cardiol; 2014 Feb; 113(4):593-600. PubMed ID: 24484860
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
[TBL] [Abstract][Full Text] [Related]
40. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
